Thomas J. Shaw Purchases 20,000 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Posted by Amy Steele on May 22nd, 2024

Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw acquired 20,000 shares of the business’s stock in a transaction dated Tuesday, May 21st. The stock was acquired at an average cost of $0.90 per share, with a total value of $18,000.00. Following the completion of the transaction, the chief executive officer now owns 14,442,749 shares of the company’s stock, valued at $12,998,474.10. The transaction was disclosed in a filing with the SEC, which is available at this link.

Retractable Technologies Stock Performance

RVP traded down $0.03 on Wednesday, reaching $0.89. The company had a trading volume of 216,187 shares, compared to its average volume of 81,929. The company’s fifty day moving average is $1.11 and its 200 day moving average is $1.15. The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.18 and a current ratio of 11.02. The stock has a market cap of $26.52 million, a P/E ratio of -3.48 and a beta of 2.11. Retractable Technologies, Inc. has a fifty-two week low of $0.87 and a fifty-two week high of $1.34.

Retractable Technologies (NYSE:RVP – Get Free Report) last posted its earnings results on Wednesday, May 15th. The company reported $0.01 EPS for the quarter. The company had revenue of $7.60 million for the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on Retractable Technologies in a report on Sunday. They set a “hold” rating for the company.

Get Our Latest Report on Retractable Technologies

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.